LAM Test: A New Cognitive Marker for Early Detection in Preclinical Alzheimer’s Disease
0
Authors
María García-Martínez
María García-Martínez•Ana Pozueta‐Cantudo•Pascual Sánchez‐Juan
Published
June 28, 2024
Abstract
With the arrival of disease-modifying treatments, it is mandatory to find new cognitive markers that are sensitive to Alzheimer's disease (AD) pathology in preclinical stages.